Table 4.

		N	%
				Total		36	100.00
Age at time of surgery	Median (range)	63.3 (32.5–76.6)
Sex	Male	23	63.89
	Female	13	36.11
Race	Black/African American	9	25.00
	White/Caucasian	27	75.00
Histologic subtype	Clear cell RCC	27	75.00
	Other RCC	9	25.00
Treatment	Nivolumab	14	38.89
	Ipilimumab+nivolumab	12	33.33
	Cabozantinib+nivolumab	6	16.67
	Levatinib+nivolumab	1	2.78
	Atezolizumab	1	2.78
	Axitinib+avelumab	1	2.78
	Study drug+ipilimumab+nivolumab	1	2.78
Histologic subtype	Clear cell RCC	27	75.00
	Other RCC	9	25.00
Stage at diagnosis	I	2	5.56
	II	2	5.56
	III	13	36.11
	IV	19	52.78
%CD8 strata	High	10	27.78
	Low	26	72.22
%CD8	Median (range)	1.1 (0.0–24.5)

RCC, renal cell carcinoma.